David E. I. Pyott
Director at Alnylam Pharmaceuticals; Director at BioMarin Pharmaceutical; Director at Tarsus Pharmaceuticals. Based in Cambridge, Massachusetts.
- Rank
- 9618th of 14,644
- Companies held
- 3
- Largest holding
- ALNY, 55.7% of total
- Latest SEC filing
- Nov 10, 2026
What the $8.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals ALNY Common Stock | Through Trust | 27,900 | $148.99 | $4.2M | 46.7% | Form 4, Nov 10, 2026 |
| BioMarin Pharmaceutical BMRN Common Stock | Directly | 49,750 | $62.22 | $3.1M | 34.8% | Form 4, May 21, 2024 |
| Alnylam Pharmaceuticals ALNY Common Stock | Directly | 5,362 | $148.99 | $799K | 9.0% | Form 4, Nov 10, 2026 |
| Tarsus Pharmaceuticals TARS Common Stock | Through the David E.I. Pyott Trust | 9,575 | $76.90 | $736K | 8.3% | Form 4, Sep 15, 2026 |
| Tarsus Pharmaceuticals TARS Common Stock | Directly | 1,383 | $76.90 | $106K | 1.2% | Form 4, Apr 24, 2026 |
Share counts are the amounts David E. I. Pyott reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9615 | Ann S. Moore Director, Royal Caribbean Cruises. Miami, FL | $8.9M |
| 9616 | Camille L. Bedrosian Chief Medical Officer, Amylyx Pharmaceuticals. Cambridge, MA | $8.9M |
| 9617 | Zvi Alon CEO / Chairperson, Tigo Energy. Los Gatos, CA | $8.9M |
| 9618 | David E. I. Pyott Director, Alnylam Pharmaceuticals. Cambridge, MA | $8.9M |
| 9619 | Christopher M.t. Thompson Director, Jacobs Solutions. Chantilly, VA | $8.9M |
| 9620 | Hanseung Kang Rep Director, Business Mngmt, Coupang. Seattle, WA | $8.9M |
| 9621 | John C. Frey Executive Vice President, Kayne Anderson Energy Infrastructure Fund. Houston, TX | $8.9M |
Other Alnylam Pharmaceuticals insiders
All ALNY insiders- Phillip A. Sharp$39.8MDirector. #2936 overall
- John Maraganore$34.4MChief Executive Officer. #1986 overall
- Yvonne Greenstreet$12.7MChief Executive Officer. #7154 overall
- Jeffrey Poulton V.$9.2MEVP, Chief Financial Officer. #9351 overall
- Tolga Tanguler$5.1MEVP, Chief Commercial Officer. #14280 overall
- Akshay Vaishnaw$3.5MPresident. #3319 overall
Questions
How much stock does David E. I. Pyott own?
David E. I. Pyott holds $8,893,821 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 9618th on the Stock Rich List.
Is this David E. I. Pyott's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did David E. I. Pyott last buy or sell stock?
The most recent open-market trade on file is a sale of 1,175 ALNY shares on Jun 1, 2026 at $298.91.